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Pn Algorithm to Predict Implantable
ardioverter-Defibrillator Lead Failure
ruce D. Gunderson, MS,* Amisha S. Patel, MS,* Chad A. Bounds, BSEE,* Richard K. Shepard, MD,†
ark A. Wood, MD, FACC,† Kenneth A. Ellenbogen, MD, FACC†
inneapolis, Minnesota; and Richmond, Virginia
OBJECTIVES The goal of this analysis was to test an algorithm that identifies implantable cardioverter-
defibrillator (ICD) lead problems before clinical failure and/or inappropriate therapy.
BACKGROUND The ICD lead failures typically present as inappropriate shock therapy. Identifying lead
failures before their clinical presentation may prevent patient discomfort, improve device
longevity, and avoid device-induced proarrhythmia.
METHODS We tested an algorithm that uses two measures of oversensing and one measure of abnormal
impedance to detect a lead failure. The oversensing measures consisted of a counter for RR
intervals 140 ms and nonsustained ventricular tachycardia episodes with mean RR interval
200 ms. The impedance measure tracked lead impedances every day and each week.
Abnormal impedance was defined as a decrease in impedances or an outlier value compared
with baseline. Lead failures were identified when both oversensing measures were met or
abnormal impedance and one oversensing measure occurred. The stored data from 696
patients with an ICD were analyzed to determine the sensitivity and specificity of the
algorithm to detect lead failures.
RESULTS Twenty-nine patients demonstrated clinical lead failures with an average of 6  9
inappropriate shocks per patient. The two oversensing measures used in the algorithm
predicted 72% (21 of 29) of the lead failures. Fulfilling at least two of the three impedance
and oversensing measures, the sensitivity of our algorithm was 83% (24 of 29) with a 100%
(667 of 667) specificity.
CONCLUSION Oversensing combined with abnormal impedance trends may be used to identify ICD lead
failures with high sensitivity and very high specificity. (J Am Coll Cardiol 2004;44:

























she implantable cardioverter-defibrillator (ICD) has be-
ome the treatment of choice for patients with life-
hreatening ventricular tachyarrhythmias (1,2). Implantable
ardioverter-defibrillators rely on accurate sensing of the
entricular rhythm for appropriate detection of ventricular
achycardia. Oversensing of other events (e.g., noise due to
ead failure, T waves, myopotentials, electromagnetic
nterference) may cause inappropriate therapies. Lead fail-
res are one of the most common causes of oversensing
esulting in inappropriate shocks. A lead failure may also
resent with failure to sense ventricular tachycardia or
entricular fibrillation, inability to terminate ventricular
achyarrhythmias, or induction of ventricular tachyarrhyth-
ias (“proarrhythmia”).
The ICD leads are significantly more complex in design
han pacemaker leads and may be more susceptible to lead
ailure (3–9). The higher sensitivity used in ICD sense
mplifiers makes them more susceptible to oversensing of
oise signals than pacemakers.
The purpose of our study was to test an algorithm that
as designed to detect abnormal ICD lead malfunction in
From *Medtronic, Inc., Minneapolis, Minnesota; and the †Division of Cardi-
logy, Medical College of Virginia/Virginia Commonwealth University, Richmond,
irginia. Gunderson, Patel, and Bounds are Medtronic employees. Drs. Ellenbogen
ndWood are Medtronic consultants, and Drs. Ellenbogen, Wood, and Shepard have
eceived Medtronic scientific grants.i
Manuscript received December 4, 2003; revised manuscript received June 30, 2004,
ccepted July 29, 2004.atients with a wide variety of ICD leads before the clinical
resentation of lead failure.
ETHODS
mpedance measurements. The GEM (Medtronic Inc.,
inneapolis, Minnesota) family of ICDs performs sub-
hreshold lead impedance measurements to monitor multi-
le conductor fracture and insulation breach scenarios. For
he pacing impedance measurement, a subthreshold
00 mV, 60 s pulse is delivered from tip to ring, and
oltage is measured between these conductors. The voltage
nd current measurements are used to calculate the imped-
nce (voltage/current). The high voltage (HV) impedances
re measured with a subthreshold 400 mV, 60 s pulse
elivered from the tip to an HV electrode (e.g., right
entricular [RV] coil). The voltage is measured between the
ame HV electrode (e.g., RV coil) and a different electrode
e.g., ring). For example, the ring-to-RV coil impedance is
easured with a current resulting from a pulse delivered
etween the tip-to-RV coil, and the observed voltage
ifference between ring-to-RV coil. All impedance mea-
urements are automatically made daily at 3:00 AM and
tored in device memory.
lgorithm design. The algorithm was designed using a
atabase collected retrospectively from patients with pace/
ense lead failures and patients without pace/sense oversens-
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November 2, 2004:1898–902 Predicting ICD Lead Failurexternal therapies, lead failures, and so on). Stored memory
ata used for the three components of the algorithm
ncluded the sensing integrity counter (SIC), nonsustained
achycardia (NST) episode log, and impedance trends. If at
east two of the three components were satisfied, then a lead
ailure was said to occur.
Oversensing due to a lead failure often occurs soon after
he blanking period of the sense amplifier (e.g., 120 ms).
he SIC quantifies this oversensing by incrementing for RR
ntervals 140 ms. A date/time stamp indicates when the
ounter first increments since the last ICD interrogation.
n average SIC per day was calculated by dividing the SIC
y the fraction of days from the first count to the date/time
tamp of the current ICD interrogation. If the SIC per day
as 10 counts or the SIC total was 300, then the first
omponent was satisfied.
Consecutive oversensed events may trigger a stored inap-
ropriate NST episode. The ICD requires a minimum of
ve consecutive intervals in the tachycardia detection zones
o store an NST episode. The NST log stores up to the 50
ost recent episodes. Ventricular arrhythmias typically have
n average cycle length 200 ms, and NST episodes with
R 200 ms are likely due to oversensing. Two NST
pisodes with RR 200 ms 1 week apart were required to
atisfy the second component.
Impedance trends were stored in ICD memory for up to
ne year, including 14 daily measurements and 52 minimum
nd maximum weekly measurements. An eight-week sliding
indow was used to create a baseline value to be compared
ith the most recent impedance value. The minimum
eekly baseline was the second largest value in the current
ight-week window. The maximum weekly baseline was the
econd smallest value in the current eight-week window.
Three weekly maximum tip-ring impedances 200% of
he maximum baseline were required to indicate an abnor-
al impedance (Fig. 1). In addition, three weekly minimum
ip-ring impedances 50% of the minimum baseline were
equired to indicate an abnormal impedance trend. Gradual
egradation of lead insulation may result in a decreasing
mpedance trend. The linear slope of a five-beat overlapping
edian window over 12 weeks was calculated. At least a
5% decrease in the minimum tip-ring impedance was
onsidered abnormal (Fig. 2). Middle insulation degrada-
ion between the middle (i.e., ring) and outer (i.e., RV coil)
oaxial conductors (10,11) was characterized by ring-RV
oil impedances decreasing 15 ohms (12). An algorithm
Abbreviations and Acronyms
HV  high voltage
ICD  implantable cardioverter-defibrillator
NST  nonsustained tachycardia
RR  consecutive QRS complexes
RV  right ventricle/ventricular
SIC  sensing integrity counterequiring four of seven minimum ring-RV coil impedances
a
bo be 15 ohms was derived from the patients that
xhibited the abnormal decreasing ring-RV coil impedances
Fig. 3). The abnormal impedance criterion (i.e., third
omponent) was satisfied when any one of these impedance
lgorithms was satisfied.
Individually, each of these three components may be
atisfied during a lead failure. Each component may result in
alse positives. A high SIC may occur with R-wave double
ounting or electromagnetic interference. Multiple short
ycle length NST episodes may occur during an electrical
torm. Impedance may decrease during an increase in lung
uid. Requiring more than one component decreases the
isk of false positives.
atabase. The algorithm discussed earlier was designed
ased on our prior reported experience with ICD lead
ailures (12,13). Because the incidence of lead failures is
mall, very large and lengthy studies would be needed to
ollect enough patients with lead failures to develop and test
he algorithm. Instead, patients with confirmed lead failures
ere collected from trouble-shooting consultations and
ultiple manufacturer clinical studies (i.e., problem group).
different group was collected from patients in ICD
linical studies without oversensing problems (i.e., normal
roup). The development database included 11 patients in
he problem group and 211 patients in the normal group.
igure 1. Plot of high tip-ring impedances. The three high impedances
200% of the baseline are circled. The arrow indicates that the impedance
riteria would have triggered four weeks before the inappropriate shock
i.e., end of impedance trend). These impedances were below the 2,000-
hm fixed threshold.
igure 2. Plot of decreasing tip-ring impedances. The line shows the linear
egression fit through the decreasing impedance values over 12 weeks. The
rrow indicates the impedance criteria would have triggered three weeks
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Predicting ICD Lead Failure November 2, 2004:1898–902A different preexisting database of two patient groups was
sed to test the algorithm. The sensitivity of the algorithm
as determined using ICD data from patients in the
roblem group. The specificity of the algorithm was deter-
ined using ICD data from patients in the normal group.
tored device memory was collected from single- and
ual-chamber ICDs of the GEM family (models 7227,
229, 7231, 7271, 7273; Medtronic Inc.). Each episode
rom the problem group contained at least one inappropri-
tely detected ventricular fibrillation episode with electro-
rams. The episode electrograms, returned lead analysis
when available), clinical actions (e.g., lead replaced, lead
apped) were reviewed to confirm a lead failure (e.g.,
nsulation break or conductor fracture). The problem group
onsisted of 29 patients with a lead failure collected from
eptember 1999 to January 2002. Twelve patients had a lead
ith a multilumen body design (ICD lead models 6943: 1;
944: 4; 6945: 7; Medtronic Inc.), and 17 patients had a
ead with a coaxial body design (model 6936; Medtronic
nc.).
The normal group consisted of 667 patients with
CD lead models 6942 (n  283), 6944 (n  248), 6943
n  79), 6932 (n  28), 6945 (n  25), 6936 (n  4)
Medtronic Inc.), and Guidant Corporation (St. Paul,
innesota) model 0125 (n  1). Patients were included in
he normal group if they did not have any detected episodes
lassified as inappropriate due to oversensing by the clini-
ian or did not receive external shocks resulting in oversens-
ng observed on the detected episode. The data for this
roup was collected between December 1998 and December
000 from the ICD lead model 6944 (Medtronic Inc.) and
CD pulse generator models 7229 and 7273 (Medtronic
nc.) clinical studies. They had a mean age of 64 11 years,
3% were male, and the mean ejection fraction was 34 
4%. There was a total follow-up time of 435 patient-years.
ata analysis. The sensitivity and specificity were mea-
ured for each of the three algorithm components individ-
ally and as a combined algorithm. The time from predic-
ion to an inappropriate detection was estimated using the
mpedance and NST components separately. Impedance
igure 3. Plot of decreasing ring-coil impedances. The four impedances
15 ohms were circled. The arrow indicates that the impedance criteria
ould have triggered 15 weeks before the inappropriate shock.rends provide continuous data over the prior 52 weeks. The pST log has limited storage and may not include the initial
ccurrence of satisfying the criteria.
Continuous variables were reported as mean values 
tandard deviation and otherwise as percentages. McNe-
ar’s exact test was used to compare sensitivity proportions
or matched pairs. A conservative approach was taken to
eep the overall error rate at 0.05 for multiple comparisons.
o implement this approach, two correlated comparisons
ere assumed to be independent. A p value 0.025 was
onsidered statistically significant using Bonferroni’s adjust-
ent.
ESULTS
e analyzed 29 patients in the problem group averaging 11
14 inappropriate detections per patient (range 1 to 56).
he time to first inappropriate detection from lead implant
as 44  27 months (range 1 to 80 months) with a median
f 55 months. On average, patients received 6  9 inap-
ropriate shocks (range 0 to 38). Shock therapy was deliv-
red on the first inappropriate detection for 31.0% (9 of 29)
f the patients. Multiple shocks were delivered to 51.7% (15
f 29) of the patients.
ensitivity. The sensitivity to identify a lead failure satis-
ying at least two of the three criteria was 82.8% (24 of 29).
hree patients had only NST episodes with no abnormal
mpedance trend (Fig. 4). One patient only satisfied the SIC
riteria, and one patient did not satisfy any of the three
riteria. Using only the two oversensing criteria, the sensi-
ivity was 72.4% (21 of 29). Using abnormal impedance and
ither of the two oversensing criteria, the sensitivity was
1.4% (12 of 29). All abnormal impedance trends had at
east one oversensing criteria satisfied. The sensitivity using
nly the fixed threshold (e.g., 2,000 ohms) was 6.9% (2 of
9). Both the two of three criteria and the two oversensing
riteria were significantly better than the fixed threshold of
,000 ohms (p 0.0001 for both comparisons). The NST
ad the highest individual sensitivity of 89.7% (Table 1).
There were 37.9% (11 of 29) patients with abnormal
mpedance before an inappropriately detected episode. One
igure 4. Venn diagram showing the number of patients satisfying each of
he three lead failure components. Each of the 29 patients could satisfy
ero, one, two, or all three components. NST  nonsustained tachycardia
pisodes; OS  oversensing; SIC  sensing integrity counter; Z 
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November 2, 2004:1898–902 Predicting ICD Lead Failurehe abnormal impedance occurred after the only detected
pisode that did not result in a shock. Three patients had
ultilumen leads (Fig. 5), and eight patients had coaxial
eads (Fig. 6). The mean time from abnormal impedance to
nappropriate ventricular fibrillation detection was 8.1 7.2
eeks (range 1.4 to 22.0 weeks). Decreasing impedance
ccurred in 82% (9 of 11) of the patients, and high
mpedance outliers occurred in 18% (2 of 11) of the patients.
The ICD was first interrogated 31.1 39.7 days (median
5 days; range 0 to 158 days) after the first inappropriate
etection. Of the 26 patients meeting the NST criteria, 16
atients had their entire NST logs rewritten with episodes
ccurring after the first inappropriate detection. Using the
pisodes in the 16 overwritten logs, the NST criterion was
atisfied 17.1  33.3 days (median 4 days; range 0 to 134
ays) after the first inappropriate detection. The NST
riteria was satisfied 19.8 56.7 days (median 2 days; range
s to 181 days) before the first inappropriate detection for
he 10 patients without all their NST episodes before
etection. This is a less reliable estimate because the first
ST episodes satisfying the criteria could have been over-
ritten.
pecificity. There were no false positives in the normal
roup during 435 patient-years resulting in a specificity of
00%. The impedance trend had the highest individual
pecificity of 99.7% (Table 1).
ISCUSSION
e have developed and tested an algorithm that has a high
ensitivity and specificity for detecting ICD lead failure
efore inappropriate detection and therapy. The combined
se of impedance measurements and quantitative measures
f oversensing were able to detect lead failures in over 80%
able 1. Individual Algorithm Component Performance
Criteria Sensitivity Specificity
NST 89.7% (26/29) 99.6% (663/667)
SIC 79.3% (23/29) 96.3% (642/667)
Z 41.4% (12/29) 99.7% (665/667)
ST  nonsustained episodes; SIC  sensing integrity counter; Z  impedance.
igure 5. Plot of abnormal tip-ring impedances from three patients witht
ultilumen leads. The circles indicate where the impedance criteria would
ave triggered before the inappropriate shock.f patients, with no false positive detections. The algorithm
rovided a 20-day average warning period that would be
nough warning to prevent morbidity in most patients.
ecause the major consequence of ICD lead failure is
nappropriate ICD shock therapy, the implementation of
uch an algorithm may have a major benefit to patients who
ave ICD leads when this algorithm is tested prospectively
n large patient populations and is determined to predict
uture inappropriate clinical events. An unidentified lead
racture could cause failure to convert ventricular tachycar-
ia or fibrillation and may result in the patient’s death.
The recent publication of the Multicenter Automatic
efibrillator Implantation Investigators Trial (MADIT) II
uggests increasing numbers of patients will be receiving
CD therapy (14). In addition to increased ICD implanta-
ion rates, increasing survival of patients with congestive
eart failure has been reported (15). The net effect of these
wo trends is that more patients will have ICD leads for
onger periods of time. This will result in increased number
f patients at risk of ICD lead failure.
This algorithm would be most valuable implemented in
n ICD. The lead system could be checked on a daily basis
r more frequently. The individual algorithm components
sed in this study could be implemented as designed or
mplemented with minor modifications into a basic ICD
omputer processor. A trigger could sound an alert within
he ICD to signal the patient to contact their clinic and
eceive the necessary care. Also, a patient followed remotely
ould have a warning triggered and sent to the central server
or appropriate action.
We designed an algorithm that measured both oversens-
ng and lead impedance problems. Oversensing due to lead
ailure often occurs shortly after the blanking period of the
ense amplifier (e.g., 120 ms). The SIC quantifies this
versensing. The NST episode count is a dynamic measure
f oversensing. Impedance has been used historically to
dentify lead failure when abnormally elevated or decreased
mpedance is measured. The impedance measurements with
igure 6. Plot of decreasing ring-coil impedances from eight patients with
oaxial leads. The circles indicate where the impedance criteria would have
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Predicting ICD Lead Failure November 2, 2004:1898–902leeping and thus not associated with body movement that
ay also further provoke an intermittent conductor or
nsulation break. Thus, single impedance measurements
ay have been unable to predict lead failure. Current ICDs
se only fixed impedance thresholds, such as 2,000 ohms
r 200 ohms as a trigger to indicate lead failures. Our
lgorithm incorporated these fixed impedance measure-
ents, but also used measurements of impedance trends
tored in the ICD memory for up to one year. We analyzed
rends in impedance changes over time and found them
elpful for predicting ICD lead failure. Our algorithm was
ested on a large ICD database and identified lead failures
ith an 83% sensitivity and no false positives from patients
ollowed for 435 patient-years. The algorithm detected lead
ailures at least an estimated three to eight weeks before
linical presentation.
From a clinical point of view, this algorithm may be
elpful in a number of ways. By providing warning of an
mpending lead failure, it allows the clinician to intensify
atient follow-up and plan a course of action for further
ppropriate patient management. Secondly, in a patient
ith a limited life expectancy, it allows the clinician to
eprogram the device off and avoid the delivery of inappro-
riate shocks that may be stressful to a patient and their
amily. Finally, it allows the physician to continuously
ollect information on the electrical properties of leads that
ay help identify problem leads before clinical manifesta-
ions of failure become evident.
tudy limitations. The exact time at which the two over-
ensing measures were satisfied could not be determined
xactly. We could only determine if the SIC was satisfied
hen the data was collected at a follow-up visit. The
onsustained episodes were stored in a 50-episode buffer
hat may get filled up (“first in-first out”). The earliest
pisodes were lost if more than 50 episodes occurred. It is,
herefore, possible that the measures of oversensing may
ave demonstrated abnormalities earlier than the three to
ight weeks reported in our study. The algorithm was
eveloped from a group of patients with lead failures, and
hese leads do not represent a cross-section of all ICD leads
mplanted in the ICD patient population. Additionally, our
umbers are too small to make definitive observations on
articular types of leads and modes of lead failure. Finally,
e did not test how accurately the algorithm could differ-
ntiate lead failure from other noise sources (e.g., external
lectromagnetic interference, myopotentials).
onclusions. Oversensing and abnormal impedance mea-
urements provide an early warning before inappropriate
entricular fibrillation detection. Our algorithm demon-
1trated a high sensitivity and very high specificity for
dentifying ICD lead failures. This algorithm may be
mplemented in future ICD systems to identify lead failures
efore they result in painful unnecessary shocks, battery
epletion, and potential proarrhythmia.
eprint requests and correspondence: Dr. Kenneth A. Ellenbo-
en, Medical College of Virginia, PO Box 980053, Richmond,
irginia 23398-0053. E-mail: kellenbogen@pol.net.
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